Larimar Therapeutics, Inc.
LRMR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $33 | $27 | $27 | $70 |
| Short-Term Investments | $150 | $60 | $92 | $0 |
| Receivables | $1 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $11 | $3 | $2 | $2 |
| Total Curr. Assets | $195 | $90 | $121 | $72 |
| Property Plant & Equip (Net) | $4 | $4 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $1 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $2 | $2 |
| Total NC Assets | $5 | $6 | $6 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $200 | $96 | $126 | $79 |
| Liabilities | – | – | – | – |
| Payables | $2 | $1 | $2 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $21 | $7 | $8 | $7 |
| Total Curr. Liab. | $24 | $10 | $11 | $9 |
| LT Debt | $4 | $5 | $5 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $5 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $5 | $6 |
| Total Liabilities | $28 | $14 | $16 | $14 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$269 | -$189 | -$152 | -$116 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $441 | $270 | $262 | $181 |
| Total Equity | $172 | $82 | $111 | $64 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $200 | $96 | $126 | $79 |
| Net Debt | -$28 | -$21 | -$21 | -$64 |